Google- Salix, FDA discuss new drug application - Triangle Business Journal
| <img alt="" height="1" width="1" />Salix, FDA discuss new drug applicationTriangle Business Journal8 to discuss the application for rifaximin, a product being developed for non-constipation irritable bowel syndrome. Salix (Nasdaq: SLXP) said it discussed ...News and FDA Updates for Salix (NASDAQ:SLXP), Enzo (NYSE:ENZ), Lannett (NYSE:LCI)<nobr>American Chronicle</nobr><nobr>all 5 news articles »</nobr> |
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
